Annual Total Long Term Liabilities
$23.78 M
-$1.48 M-5.86%
December 1, 2024
Summary
- As of March 11, 2025, RCKT annual total long term liabilities is $23.78 million, with the most recent change of -$1.48 million (-5.86%) on December 1, 2024.
- During the last 3 years, RCKT annual total long term liabilities has risen by +$3.65 million (+18.15%).
- RCKT annual total long term liabilities is now -56.51% below its all-time high of $54.69 million, reached on December 31, 2020.
Performance
RCKT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$23.78 M
-$155.00 K-0.65%
December 1, 2024
Summary
- As of March 11, 2025, RCKT quarterly total long term liabilities is $23.78 million, with the most recent change of -$155.00 thousand (-0.65%) on December 1, 2024.
- Over the past year, RCKT quarterly long term liabilities has stayed the same.
- RCKT quarterly long term liabilities is now -63.89% below its all-time high of $65.86 million, reached on June 30, 2020.
Performance
RCKT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RCKT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.9% | 0.0% |
| 3 y3 years | +18.1% | -1.7% |
| 5 y5 years | -48.9% | -1.7% |
RCKT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.9% | +18.1% | -5.9% | +20.3% |
| 5 y | 5-year | -56.5% | +18.1% | -63.9% | +20.3% |
| alltime | all time | -56.5% | +6380.1% | -63.9% | +6978.0% |
Rocket Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $23.78 M(-5.9%) | $23.78 M(-0.6%) |
| Sep 2024 | - | $23.94 M(-1.0%) |
| Jun 2024 | - | $24.18 M(-3.2%) |
| Mar 2024 | - | $24.98 M(-1.1%) |
| Dec 2023 | $25.26 M(+10.1%) | $25.26 M(+4.4%) |
| Sep 2023 | - | $24.20 M(-1.1%) |
| Jun 2023 | - | $24.46 M(-0.9%) |
| Mar 2023 | - | $24.68 M(+7.5%) |
| Dec 2022 | $22.95 M(+14.0%) | $22.95 M(+16.1%) |
| Sep 2022 | - | $19.77 M(-0.5%) |
| Jun 2022 | - | $19.87 M(-0.5%) |
| Mar 2022 | - | $19.96 M(-0.8%) |
| Dec 2021 | $20.13 M(-63.2%) | $20.13 M(+0.2%) |
| Sep 2021 | - | $20.09 M(-0.9%) |
| Jun 2021 | - | $20.27 M(-63.8%) |
| Mar 2021 | - | $55.99 M(+2.4%) |
| Dec 2020 | $54.69 M(+17.6%) | $54.69 M(-11.4%) |
| Sep 2020 | - | $61.70 M(-6.3%) |
| Jun 2020 | - | $65.86 M(+0.4%) |
| Mar 2020 | - | $65.59 M(+41.0%) |
| Dec 2019 | $46.52 M | $46.52 M(+1.5%) |
| Sep 2019 | - | $45.81 M(+1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $45.13 M(+1.5%) |
| Mar 2019 | - | $44.49 M(+6.2%) |
| Dec 2018 | $41.90 M(-16.1%) | $41.90 M(+2.0%) |
| Sep 2018 | - | $41.07 M(+1.8%) |
| Jun 2018 | - | $40.35 M(+1.7%) |
| Mar 2018 | - | $39.68 M(-20.5%) |
| Dec 2017 | $49.94 M(+1.0%) | $49.94 M(+0.3%) |
| Sep 2017 | - | $49.81 M(+0.6%) |
| Jun 2017 | - | $49.52 M(+0.3%) |
| Mar 2017 | - | $49.39 M(-0.1%) |
| Dec 2016 | $49.44 M(>+9900.0%) | $49.44 M(+0.6%) |
| Sep 2016 | - | $49.14 M(>+9900.0%) |
| Jun 2016 | - | $336.00 K(-4.3%) |
| Mar 2016 | - | $351.00 K(-4.4%) |
| Dec 2015 | $367.00 K(-99.3%) | $367.00 K(-9.6%) |
| Sep 2015 | - | $406.00 K(-97.7%) |
| Jun 2015 | - | $17.52 M(-8.4%) |
| Mar 2015 | - | $19.12 M(-61.7%) |
| Dec 2014 | $49.86 M(+2.7%) | $49.86 M(+1402.6%) |
| Sep 2014 | - | $3.32 M(-93.2%) |
| Dec 2013 | $48.54 M(+69.8%) | $48.54 M |
| Dec 2012 | $28.59 M | - |
FAQ
- What is Rocket Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Rocket Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Rocket Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of RCKT is $23.78 M
What is the all time high annual total long term liabilities for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual total long term liabilities is $54.69 M
What is Rocket Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, RCKT annual total long term liabilities has changed by -$1.48 M (-5.86%)
What is Rocket Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of RCKT is $23.78 M
What is the all time high quarterly long term liabilities for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly total long term liabilities is $65.86 M
What is Rocket Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, RCKT quarterly total long term liabilities has changed by $0.00 (0.00%)